Fetal and Infant Health

June 28, 2024 | Controlled Substances, Fetal and Infant Health, Legal & Legislative Research, Maternal Health, Opioids, Prescription Drugs, Substance Misuse, Treatments

In this document, the Legislative Analysis and Public Policy Association (LAPPA) examines state-level statutes and regulations related to substance use during pregnancy and whether such use during pregnancy is considered child abuse or neglect in the jurisdiction. ...

March 7, 2023 | Controlled Substances, Fetal and Infant Health, Harm Reduction, Maternal Health, Model Laws, Public Health, Recovery, Substance Misuse, Treatments

The Model Substance Use During Pregnancy and Family Care Plans Act (1) provides certain protections to pregnant or postpartum individuals with a substance use disorder so that such individuals are not penalized for receiving medical treatment, including medication(s) to treat the substance use disorder and (2) establishes that an infant born affected by parental substance use disorder or showing signs of withdrawal is not, by itself, grounds for submitting a report of child abuse or neglect. ...

November 1, 2022 | Controlled Substances, Fact Sheets, Fetal and Infant Health, Maternal Health, Opioids, Substance Misuse, Treatments

There are a number of expert recommendations regarding how to identify, work with, and treat pregnant and postpartum individuals with SUD to ensure the best outcomes for both parent and child. There are also legal requirements regarding notification to state child welfare agencies of infants born affected by prenatal substance exposure or experiencing withdrawal and the creation of family care plans (also known as plans of safe care). This fact sheet provides readers with an overview of those recommendations and requirements.intervention....